Department of Biostatistics and Translational Medicine
Author : Jędrzej Chrzanowski
Obesity is one of the main risk factors for the development of type 2 diabetes as it leads to excessive production of free radicals, disruptions in glucose and fatty acid metabolism, and insulin resistance. The study focuses on understanding the role of the NUDT16L1 protein, which is a key regulator of TP53 activity. Deletion or […]
During the XXIV Scientific Congress of the Diabetes Poland, held in Katowice, we had the opportunity to celebrate the successes of our team and our colleagues. Jędrzej Chrzanowski, a student member of our Department, was awarded the Kazimierz Funk Prize for the best scientific publication in the field of diabetology and internal medicine. The awarded […]
For the past few days, our students took part in the Juvenes Pro Medicina conference. Our department was represented by: 1. Mateusz Łaszczych – “Dosimetric predictors of the severity of lymphocyte depletion among patients undergoing radical radiotherapy for non-small cell lung cancer” achieving first place in the oncology original research session. The first place qualified […]
We are pleased to inform you that our young scientists – Agata Kozajda and Julia Świerczyńska have been qualified for the Mentoring Program “Jutronauci” under the patronage of Gazeta Wyborcza. For a year, they will develop their scientific skills and search for their dream career path under the supervision of Igor Kaczmarczyk, a PhD student […]
Type 1 diabetes (T1D) is the most common metabolic disease in childhood. It is caused by the destruction of pancreatic beta cells by one’s malfunctioning immune system. The lost beta cells are responsible for the production of insulin – an essential hormone in blood glucose levels regulation. Treatment of T1D demands life-long subcutaneous insulin supplementation […]
Transplantation of hematopoietic stem cells from bone marrow is a widely used method for treating various diseases, such as blood cancers, metabolic disorders, and autoimmune diseases. However, some patients are unable to undergo this procedure effectively due to problems with mobilizing an adequate number of stem cells. The study proposes to evaluate the role of […]
The project aims to investigate the role of proinsulin C-peptide and G-protein coupled receptor 146 (GPR146) in type 2 diabetes mellitus (T2DM) complications. C-peptide is a short peptide that influences multiple cellular pathways, and its role in diabetes complications has become increasingly evident. The study postulates that C-peptide interacts with the GPR146 receptor, which may […]
We are pleased to inform about the success of our Ph.D. student Damian Mikulski, M.D. – the results of the ATLAS clinical trial (PMC006) in which he participated were published in the Lancet Oncology (IF 54.433) in the manuscript “Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients […]
It is our pleasure to inform you that Arkadiusz Michalak, M.D., has been selected to participate in the TopMinds 2023 program under the mentorship of prof. Marcin Waligóra. Congratulations!
We are pleased to announce that Konrad Stawiski, M.D., PhD was awarded distinction by StatSoft Poland and Polish Statistical Association for the best doctoral dissertation in 2022. Congratulations! You can read more here.
